RPSAP75

Across TCGA pan-cancer cohorts, RPSAP75 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RPSAP75 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RPSAP75 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPSAP75 expression acts as an unfavorable survival marker, although some lineages such as OV and LUSC show a favorable association.

LUAD, ACC, and UVM are the cancer types where RPSAP75 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.364	0.817	.001	72	view →
ACC	DFS	Tertile	All	0.286	0.661	<.001	69	view →
UVM	OS	Median	All	0.750	1.000	.004	44	view →
KIRC	DFS	Tertile	IV	0.171	0.431	.005	26	view →
OV	DFS	Tertile	IV	0.586	0.343	.014	24	view →
THCA	DFS	Tertile	IV	0.416	0.938	.001	18	view →
KICH	OS	Tertile	All	0.718	0.942	.016	15	view →
UCEC	DFS	Median	All	0.499	0.771	.003	12	view →
KIRP	OS	Tertile	All	0.900	0.967	.004	10	view →
READ	DFS	Median	All	0.409	0.800	.006	7	view →
STAD	DFS	Median	All	0.370	0.663	.027	6	view →
LGG	DFS	Tertile	All	0.234	0.469	.019	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RPSAP75–LUAD (DFS)

Open the LUAD breakdown →